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Objectives. Contralateral responses to unilateral stimuli have been well described in animal models. These range from central sensitization
to peripheral inflammatory responses. Our aim was to test for contralateral responses following unilateral intradermal capsaicin injection
in man.
Methods. Three groups were investigated. A healthy volunteer group (1) was injected with capsaicin into the volar aspect of one forearm.
A group of patients with RA (2) was also injected with capsaicin. A control group of healthy volunteers (3) was not injected with capsaicin.
All groups were tested for hyperalgesia and allodynia every 10min for 1h following the injection using quantitative sensory testing.
Results. A total of 9/14 healthy volunteers (Group 1) and 10/14 patients with RA (Group 2) demonstrated contralateral sensitization that
subsided within 1h following intradermal capsaicin injection. A total of 2/23 control subjects (Group 3) demonstrated positive responses with
the monofilaments. The frequency of the contralateral responses in the experimental groups compared with the control group is significant
(P<0.05). The peak hyperalgesia was relatively delayed contralaterally compared with the ipsilateral side (35min vs 15min). The area of
sensitization, where present, was reduced compared with the ipsilateral side (5–50%).
Conclusions. This is the first demonstration of a contralateral response following a unilateral stimulus in man. Bilateral neural pathways
mediating contralateral responses may have a role in the pathophysiology of chronically painful or inflammatory diseases and a confounding
influence on using the contralateral limb as a control experimentally. We did not find that a systemic inflammatory disease sensitized for this
phenomenon.
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Introduction
The nervous system is anatomically symmetrical, both periph-
erally and centrally at the spinal level. The two sides of the spinal
column are thought to function independently from each other. It
is clear from decerebrate and spinalized rat models that they do
not [1, 2]. Koltzenburg et al. [3] reviewed the literature detailing
various unilateral peripheral neuronal insults that result in
contralaterally identical, albeit diminished, responses. The topo-
graphically precise nature of these contralateral responses can
only be due to neural pathways.
We have reviewed the literature concerning contralateral
responses following unilateral inflammatory lesions [4]. For
example, Bileviciute et al. [5] demonstrated neuropeptide release
from the contralateral joint of rats following a monoarthritis with
no signs of systemic inflammation. These contralateral responses
were temporally delayed and reduced in magnitude compared
with the ipsilateral side. Other groups have studied contralateral
responses by interrupting the neural supply to abrogate them,
but have not been able to do so when interrupting the circulation
[6, 7]. This also suggests a neural basis.
Using animal models several groups have described allodynia
and hyperalgesia occurring in the contralateral periphery follow-
ing an inflammatory stimulus. Stimuli that induce such sensitiza-
tion in animal models include thermal, IL-1 , bee venom,
carrageenan, formaldehyde and even repeated saline injections
[7–14]. No studies have been performed in man. However, 5%
of the patients with complex regional pain syndrome (CRPS),
a chronic pain condition with demonstrable hyperalgesia and
allodynia, documented bilateral presenting symptoms [15].
Detailed investigations, such as with technetium pertechnetate
bone scanning or quantitative sensory testing, demonstrate that
a symmetrical involvement might occur even more often than
these clinical symptoms suggest [16, 17]. Patients with RA exhibit
symmetrical disease in both their clinical symptoms of pain and
stiffness as well as radiographic damage. There is evidence that
this could be influenced by bilateral neural loops releasing pro-
inflammatory cytokines such as substance P and calcitonin gene-
related peptide (CGRP).
Our primary aim was to investigate for contralateral sensiti-
zation by testing for contralateral hyperalgesia and allodynia
following intradermal capsaicin in man. We recruited two groups
of subjects, one healthy and the other with RA. We predicted that
there might be differences in the primary outcome between the
healthy volunteer and RA groups given the above observations. In
order to control for the subjective reports of hyperalgesia and
allodynia, we recruited a control group of volunteers who did not
receive the intradermal capsaicin injection, but were subject to
similar experimental conditions.
Capsaicin (8-methyl-N-vanillyl-6-noneamide) opens the non-
selective cation channel TRPV1 receptor (vanilloid receptor 1),
located on fine sensory afferent nerve fibres. This allows an influx
of calcium ions and generates an afferent action potential that
is perceived as an intense burning pain [18–20]. Intradermal
capsaicin rapidly generates areas of mechanical and thermal
hyperalgesia and allodynia through both central and peripheral
nervous system sensitization [21, 22]. Sensory testing reliably maps
these sensitized areas for quantification [23, 24]. Areas of
mechanical hyperalgesia and allodynia produced by intradermal
capsaicin are broadly reproducible both within and between
individuals [25–27].
Materials and methods
Protocol
Volunteers were seated in a quiet temperature-controlled room
(23–248C) for 30min. An area on the volar aspect of one forearm
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the line measured from the medial epicondyle to the ulnar styloid,
and the plane perpendicular to this. An easily accessible and
readily identifiable area was selected about 12cm distal to the
elbow. The exact contralateral site to the capsaicin injection was
identified using these measurements. One hundred microlitres of
1% capsaicin (ethanol/Tween-80 vehicle) was then injected
intradermally. The capsaicin had been made up on site and
stored at 48C throughout the study. Allodynia and hyperalgesia
were then mapped every 10min over the following hour. Each
assessment was colour coded. This was done both ipsi- and
contralaterally using standard quantitative techniques (see subse-
quently) [23, 24]. Due to possible suggestion bias the volunteers
were not told of the study objective. It was explained that the
capsaicin injection would be very painful and that the study was to
assess the response to this pain. Volunteers had been told to avoid
smoking, caffeine, strenuous exercise and alcohol on the day of
the study.
Sensory detection of hyperalgesia and allodynia
Pinprick hyperalgesia was detected using a stiff Semmes Weinstein
monofilament (6.45; 1500mN) [28]. This was first tested on
a control area of skin (anterior chest wall) prior to the capsaicin
injection. Most volunteers reported that this felt like a pinprick
but was not painful. Volunteers were asked to rate whether the
monofilament on their forearm felt different to the sensation felt
over the anterior chest wall. Responses were only positive for
hyperalgesia if the volunteer reported that the sensation was
different to the surrounding skin and was more painful than
previously experienced. The central area (capsaicin injection site
or contralateral correlate) was linearly approached from eight
different directions sequentially about 30cm from the centre. Each
direction was equally spaced around 3608. The monofilament was
tested in the same direction until the centre point was reached
using intervals of about 3cm. Should a response be positive,
then the skin was marked and the next direction was tested.
Most of the surface skin of the arm (about 60cm in total length)
was covered between the shoulder and the wrist. The individual
was said to respond positively if three out of the eight approaches
elicited a positive response, as a polygon could be then
constructed from these three points and the surface area
quantified.
Allodynia was detected using a 4.74 (51.9mN) monofilament,
and again the anterior chest wall was used prior to the experiment.
This force is not normally perceived as painful, but is well above
the sensory threshold [29]. Reponses were only positive for
allodynia if the volunteer reported that the sensation was both
different to the surrounding skin and painful.
Points referring to positive responses to allodynia and
hyperalgesia were then transferred using transparent acetate
onto blank paper. Free drawn areas were described by connecting
these points and measured using MAVIS, a device used for
measuring the surface areas of irregular shapes [30]. Bath Local
Research and Ethics Committee approved the protocol and all
volunteers gave full informed consent.
Volunteers for intradermal capsaicin
Healthy volunteers were recruited from colleagues and staff at
the Royal National Hospital for Rheumatic Diseases and the
University of Bath, and had no medical diagnoses. Patients who
satisfied the American Rheumatology Association’s criteria for
RA were also recruited. They were excluded if they had
a neurological lesion. Baseline characteristics including disease
duration, medication and disease activity were collected.
Fourteen healthy volunteers [mean age 40.5yrs (range 30–72),
42.8% males] were recruited. Eighteen patients with RA were
recruited. As TNF-  is an important mediator for both peripheral
and spinal pain, patients receiving anti-TNF-  blockers (n¼4)
were excluded from this study. Fourteen patients were therefore
analysed with a mean age of 52yrs (28–66 range) and 35.7% were
males. The average duration of disease was 5.9yrs (range 2–29);
twelve were taking anti-rheumatic agents (seven patients taking
MTX; one MTX and SSZ; one gold; one AZA; one SSZ; one
LEF) and the average disease activity score (DAS) was 5.12,
indicating active disease.
Volunteers for controls with no capsaicin
Thresholds to sensory stimuli vary within the same individual
depending upon their location due to a variety of factors including
the dermal density of nociceptors and environmental cues.
Comparing volar forearm responses to anterior chest wall
responses might therefore be misleading. To help control for
such a factor, and also to control for suggestion bias, a control
group was recruited who had not been exposed to the intradermal
capsaicin. Areas of hyperalgesia and allodynia were mapped as
outlined above on the volar aspect of both forearms. Volunteers in
this group were recruited from patients, colleagues and staff at
the Royal National Hospital for Rheumatic Diseases and the
University of Bath.
Twenty-three volunteers [mean age 35.3yrs (range 23–56),
39.1% males] were recruited to this control group. Two of these
volunteers also had a diagnosis of RA.
Statistical analysis
The primary outcome was the frequency of contralateral
responses in the groups exposed to capsaicin compared with the
control group not exposed to capsaicin. The secondary outcome
was to compare the contralateral responses between the RA and
healthy groups. The non-parametric signed rank test was used to
analyse both outcomes.
Results
Control group (no capsaicin injection)
A total of 2/23 (8.7%) volunteers demonstrated areas of
hyperalgesia and allodynia that both felt different and was more
painful than the surrounding tissue on the volar aspect of
the forearm. Neither volunteer who responded had RA. One
volunteer had areas of hyperalgesia and allodynia of 86.4 and
76.2cm
2, respectively, while the other responder had areas of 4.2
and 3.6cm
2, respectively.
Healthy and RA groups (capsaicin injection)
A total of 9/14 (64.3%) healthy controls demonstrated contra-
lateral hyperalgesia or allodynia within an hour. A total of 10/14
(71.4%) patients with RA demonstrated contralateral sensory
changes. Both groups demonstrated statistically significant
differences in the frequency of contralateral responses when
compared with the control group (P<0.05). In the healthy group,
this achieved significance for hyperalgesia at 5, 15 and 25min and
for allodynia at 15, 25, 35 and 45min. In the RA group, this
achieved significance for hyperalgesia at 15, 25, 35 and 45 min,
but did not achieve significance for allodynia at any time point.
When both groups were combined (Fig. 1), the percentage of
responders who demonstrated contralateral hyperalgesia reached
significance at time points of 15, 25, 35 and 45min and those
exhibiting contralateral allodynia reached significance at 15, 25
and 35min. The time point with the highest frequency of
contralateral responses was at 15min for contralateral hyperalge-
sia and at 25min for contralateral allodynia. This compares with
maximal areas of hyperalgesia and allodynia on the ipsilateral side
at 15min and between 5 and 25min respectively.
The mean of the maximal ipsilateral hyperalgesic area after
capsaicin was injected was 17.0cm
2 (S.E.M. 3.1). This was
significant (P<0.05) when compared with the maximal area of
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2 (S.E.M. 0.7). The mean of the
maximal ipsilateral allodynic area following intradermal capsaicin
was 14.4cm
2 (S.E.M. 2.4), again significant (P<0.05) compared
with the contralateral allodynia, 6.1cm
2 (S.E.M. 0.8). In the
volunteers who demonstrated responses, the maximal contra-
lateral area varied in magnitude between 5% and 50% of the
maximal ipsilateral response to capsaicin (Fig. 2).
There were no significant differences between the proportions
of healthy volunteers and patients with RA who described
contralateral sensations following capsaicin injection. There was
no difference in the temporal pattern of the responses in these two
groups. Both groups demonstrated an increase in the frequency of
contralateral sensitization that reflected the frequency of the pain
responses to the capsaicin injection. There were no differences in
the size of the contralateral response between these groups.
There was no correlation between the baseline characteristics of
the volunteer groups and the presence of a contralateral response.
These were age, sex and, for the RA group, the disease duration,
activity and medication as well.
Discussion
We have described novel areas of contralateral hyperalgesia and
allodynia occurring in a significant proportion of both healthy
volunteers and patients with RA following an intradermal
injection of capsaicin using a standardized quantitative sensory
testing technique. These changes were not seen in a sample
population who had not been exposed to intradermal capsaicin.
The contralateral responses mapped a similar time course to the
allodynia and hyperalgesia ipsilateral to the capsaicin injection.
No differences were seen between healthy controls and patients
with RA in the frequency or size of this phenomenon. Although
contralateral sensitization following a unilateral inflammatory
stimulus has been described in several animal models, this is the
first experimental description of topographically precise contra-
lateral sensitization occurring in man.
Supraspinal pathways are bilaterally activated by unilateral
stimuli that might be noxious or non-noxious [31]. Primary and
secondary sensory cortex is bilaterally activated by vibrotactile
non-noxious stimulation. Noxious stimuli, however, activate
bilateral regions of the brain associated with descending control
pathways including the thalamus and rostral ventral medulla
providing a putative mechanism for mediating altered spinal
gating contralaterally [32, 33]. This pathway could give a plausible
explanation for the contralateral observation but this study gives
no information concerning higher CNS responses. The time
period between the capsaicin injection and testing the contra-
lateral side was several minutes, which is too long an interval to
differentiate whether the contralateral response occurs either
directly through the spinal cord or is mediated via long
supraspinal pathways.
Contralateral responses studied in animal models demonstrate
changes in metabolism and genomic expression in the contra-
lateral dorsal horn following an inflammatory lesion. These are
temporally consistent with a functional contribution towards any
contralateral peripheral response [34–37]. Furthermore, several
histopathologists have anatomically identified the pathways that
might mediate such contralateral responses at the spinal level.
Fibres have been identified to enter the dorsal horn and cross the
mid-line through the posterior commissure terminating in the
superficial laminae of the contralateral dorsal horn. Other fibres
synapse ipsilaterally before decussating to either the deep or
superficial laminae of the contralateral dorsal horn [39, 40].
Koltzenburg et al. [3] suggested the existence of ‘slow’ messengers,
possibly nerve growth factors, to explain the contralateral
peripheral responses seen following unilateral neural injuries.
Communication across the mid-line may be caused by reactions in
cell soma and structural changes including sprouting across the
mid-line. Alternatively, transmedian commissural interneurons
may transmit signals, but rapid synaptic activity is one-way
whereas bidirectional flow could be achieved through slower
trophic factors. Our results suggest the existence of ‘fast’
messengers because the central sensitization and contralateral
peripheral vascular response occurred within 1h of the capsaicin
injection [3].
Pando et al. [41] studied patients with less than a 12-month
history of arthritis symptoms by taking specimens from clinically
uninflamed joints. Their results confirmed that histological
evidence of synovitis can be present, as defined by increased
thickness of the synovial lining layer, altered morphology of
synovial cells, perivascular and interstitial cellular infiltrates and
increased vascularity in these clinically ‘normal’ joints [41]. Further
investigationintosuchobservationsisneededtostudytheexistence
of peripheral changes contralateral to an inflammatory stimulus in
man. Using a power calculation corrected for the non-parametric
data distribution, 81 patients would need to be recruited for the
contralateral allodynic responses to be significantly different
between the RA and healthy control groups at 25min using an
 ¼0.05 and  ¼0.80.
This could be done using more sensitive neurophysiological
techniques such as functional imaging. Peripheral induction of
a contralateral response completes the loop between homologous
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FIG. 2. The area of responses to intradermal capsaicin over time (n¼28). White
and black bars are ipsilateral hyperalgesia and allodynia respectively. Grey bars
and white-on-black dotted bars are contralateral hyperalgesia and allodynia
respectively. Hyperalgesic responses of subjects not exposed to capsaicin are
represented by the dashed line. Standard error bars are shown.
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FIG. 1. The percentage of responders to intradermal capsaicin over time (n¼28).
White and black bars are ipsilateral hyperalgesia and allodynia respectively. Grey
bars and white-on-black dotted bars are contralateral hyperalgesia and allodynia
respectively. Hyperalgesic responses of subjects not exposed to capsaicin are
represented by the dashed line.
 P<0.05 for the capsaicin-injected group
compared with the non-injected control group. There were no differences between
the RA and control groups and both groups (data not shown).
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The role of these pathways in symmetrical diseases such as RA
and skin psoriasis is an important question to be investigated as
it could lead to new therapeutic strategies. The role of these
pathways in chronically painful conditions, such as CRPS, also
needs to be explored further.
It is interesting to note that patients with RA did not exhibit
different responses when compared with the normal control
group. This may be because this study was not powered to detect
such differences but may also illustrate the lack of appropriate
stimulus and detection mechanisms. This could be studied further
by examining the contralateral inflammatory response histologi-
cally in patients with RA and normal controls.
Work on animal models has suggested that the tachykinins are
important chemical mediators for neurogenically transmitted
inflammation. For example, Decaris et al. [6] produced a model
of contralateral cartilage degeneration following a monoarthritis
induced by complete Freund’s adjuvant. They were able to
ameliorate this change by injecting neurokinin-1 antagonist
intrathecally prior to arthritis induction. Kidd et al. [42] induced
a monoarthritis using latex spheres injected into the right knee of
male Wistar rats. Contralateral knee cellular infiltrates, mainly
monocytes, were significantly elevated when compared with
control animals and joints elsewhere in the affected rat. The
neonatal administration of capsaicin, which is known to reduce
the expression of tachykinins, reduced this contralateral cell count
whilst having no effect on the ipsilateral arthritic joint. Donaldson
et al. [43] induced a monoarthritis with Freund’s complete
adjuvant in the left ankle of adult male Han Wistar rats that
had previously been shown to spread to the contralateral joint.
The application of capsaicin to the sciatic nerve 2 weeks prior to
the arthritis induction prevented the full expression of this
contralateral arthritis.
There are clear difficulties in evaluating hyperalgesia and
allodynia responses in man related to the subjectivity of the
sensory experience. It may therefore be argued that the
contralateral responses are the result of the experimental design.
However, it must be emphasized that none of the volunteers were
aware of the objective of the experiment. Furthermore, the
sensations in the contralateral area changed over time reflecting
the dynamic changes on the ipsilateral side, which suggests an
underlying physiological mechanism rather than an artefact. The
responses were remarkably consistent between volunteers. Finally,
we obtained a control group for the allodynia and hyperalgesia
responses to the Semmes Weinstein monofilaments that had not
been exposed to capsaicin. A total of 2/23 (8.7%) of this group
were seen to demonstrate allodynic and hyperalgesic responses
that were different to that felt over the chest wall. Both of these
responses are significantly lower in both frequency and magnitude
than in either of the experimental groups.
The observed contralateral responses are unlikely to reflect a
global change in pain thresholds as only the topographically
precise contralateral area was sensitized and there was no
sensitization of anatomically mismatched areas, even though
these were tested using quantitative sensory testing. The responses
are therefore a result of a specific contralateral effect rather than
a generalized sensitization of the central nervous system.
Some volunteers did not exhibit contralateral sensory changes.
This is most likely to be because the threshold to generate
contralateral central sensitization had not been reached. It may
also have been that the testing equipment was not sensitive enough
to detect contralateral changes, or, albeit less likely, the pathways
needed to generate contralateral central sensitization are not
present in everyone. This last point implies that a degree of genetic
control could exist in these pathways.
We chose to quantitatively assess contralateral sensory changes
using mapping techniques rather than that of sensory thresholds
using a manual mechanical technique, similar to that which had
previously been used following intradermal capsaicin [23, 24].
Using this method, at least three positive answers in the eight
mapped directions must be given for an area to be calculated. For
the purposes of this study there are advantages of area mapping
over thresholds. First the area can be mapped quickly without
losing reliability, rather than the more temporally laborious
threshold detection. As the contralateral responses were transient
in nature, any loss of time may result in a false negative. Second,
we were concerned that the repeated pinprick stimulus at the same
location might sensitize the skin in a ‘wind-up’ phenomenon when
tested over an hour resulting in a false positive.
In conclusion, this is the first description of contralateral
sensory changes occurring in man. This has implications on the
planning of experiments using contralateral body parts as internal
controls. The existence of neural pathways that affect the
contralateral limb is of the utmost importance when planning
such experiments, especially when assessing responses to noxious
stimuli. Internal controls should be used in such experiments. This
contralateral observation also has implications for the pathophys-
iology of chronic symmetrical inflammatory diseases, including
RA and skin psoriasis.
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